HAND & WRIST
Open release versus corticosteroid injection for treatment of trigger finger
This report has been verified
by one or more authors of the
original publication.
J Hand Surg Am. 2017 May;42(5):359-366
165 patients with trigger finger were randomized to open release of the A1 pulley or to treatment with a corticosteroid injection. Patients were assessed for reduction in Trigger Finger Score grade to either I or IIa, representing normal movement of the finger. Follow-up was performed at 3 and 12 months after treatment. At both 3 and 12 months, the open release group demonstrated a higher percentage of patients with a Trigger Finger Score of I or IIa when compared to the corticosteroid injection group. Within the corticosteroid injection group, a large percentage of patients experienced recurrence between the 3- and 12-month follow-up time points.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
